Skip to main content
. 2018 Oct 31;2018(10):CD001023. doi: 10.1002/14651858.CD001023.pub3

5.

5

Trial Sequential Analysis for variceal rebleeding episodes at 30 days is calculated based on control event rate of 12%; a RRR of 20%; a type I error of 2.5%, a type II error of 10%; and diversity of 0%. The DARIS of 8304 was not achieved and Z‐curve did not cross the alpha‐spending boundary (RR 0.18, alpha‐spending boundary‐adjusted CI 0.00 to 10.31).